Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity (Q51379603)

4 April 2018

title

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity (English)

1 reference

4 April 2018

0 references

0 references

1 reference

4 April 2018

Juleen Zierath

1 reference

4 April 2018

Anna Krook

1 reference

4 April 2018

Alexander V Chibalin

0 references

Alexei Kharitonenkov

1 reference

4 April 2018

R. F. E. Austin

object named as

Reginald L Austin

1 reference

4 April 2018

Fredirick Mashili

object named as

Fredirick L Mashili

1 reference

4 April 2018

author name string

Tomas Fritz

1 reference

4 April 2018

Kenneth Caidahl

1 reference

4 April 2018

Katrin Bergdahl

1 reference

4 April 2018

David E Moller

1 reference

4 April 2018

publication date

1 March 2011

1 reference

4 April 2018

Diabetes - Metabolism: Research and Reviews

published in

1 reference

4 April 2018

volume

1 reference

4 April 2018

issue

1 reference

4 April 2018

page(s)

286-297

1 reference

4 April 2018

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes

cites work

1 reference

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

21 January 2018

1 reference

Fibroblast growth factor 21 corrects obesity in mice

21 January 2018

1 reference

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

Fibroblast growth factor 21: an overview from a clinical perspective

21 January 2018

1 reference

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

21 January 2018

1 reference

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

21 January 2018

1 reference

Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

21 January 2018

1 reference

Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling

21 January 2018

1 reference

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

21 January 2018

1 reference

Structural basis for fibroblast growth factor receptor activation

21 January 2018

1 reference

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

21 January 2018

1 reference

FGF21 is an Akt-regulated myokine

21 January 2018

1 reference

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

21 January 2018

1 reference

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice

21 January 2018

1 reference

Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis

21 January 2018

1 reference

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

21 January 2018

1 reference

Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation.

21 January 2018

1 reference

Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content.

21 January 2018

1 reference

The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle

21 January 2018

1 reference

Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.

21 January 2018

1 reference

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

Fibroblast growth factor 21: from pharmacology to physiology

21 January 2018

1 reference

21 January 2018

1 reference

Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases

21 January 2018

1 reference

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

Plasma FGF-21 levels in type 2 diabetic patients with ketosis.

21 January 2018

1 reference

Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

21 January 2018

1 reference

Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.

21 January 2018

1 reference

Transcriptional profile of a myotube starvation model of atrophy.

21 January 2018

1 reference

Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice

21 January 2018

1 reference

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

21 January 2018

1 reference

The Klotho gene family as a regulator of endocrine fibroblast growth factors

21 January 2018

1 reference

Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

21 January 2018

1 reference

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

21 January 2018

1 reference

Relevant use of Klotho in FGF19 subfamily signaling system in vivo

21 January 2018

1 reference

Insulin signaling and glucose transport in insulin resistant human skeletal muscle

21 January 2018

1 reference

Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1

21 January 2018

1 reference

Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation

21 January 2018

1 reference

AMP-activated protein kinase signaling in metabolic regulation

21 January 2018

1 reference

Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats

21 January 2018

1 reference

Insulin action and insulin resistance in human skeletal muscle

21 January 2018

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

21 January 2018

1 reference

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity

21 January 2018

1 reference

Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle

21 January 2018

1 reference

7 January 2021

A substantial part of GLUT-1 in crude membranes from muscle originates from perineurial sheaths

1 reference

7 January 2021

Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle

1 reference

7 January 2021

Comparative effects of IGF-I and insulin on the glucose transporter system in rat muscle.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1177

1 reference

4 April 2018

1 reference

4 April 2018